Rogers Corporation Press Releases

ROG 
$79.15
*  
7.15
9.93%
Get ROG Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading ROG now
Exchange: NYSE
Industry: Basic Industries
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Rogers Corporation Signs Definitive Agreement to Acquire Arlon, LLC
12/19/2014 11:46:00 AM - PR Newswire
▲0.56 % Price Change since this news event. The Volume Ratio is 6.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bina Technologies is acquired by Roche.
12/19/2014 11:45:00 AM - PR Newswire


Roche acquires Bina Technologies and enters the genomic informatics market
12/19/2014 11:30:00 AM - PR Newswire


Genentech Provides Update on Phase III MARIANNE Study in People with Previously Untreated Advanced HER2-Positive Breast Cancer
12/19/2014 1:00:00 AM - Business Wire


Genentech Submits New Drug Application to FDA for Investigational Cobimetinib Used in Combination With Zelboraf (vemurafenib) in Advanced Melanoma
12/15/2014 1:00:00 AM - Business Wire


Roche Diagnostics purchases tissue dissection technology from AvanSci Bio
12/10/2014 9:00:00 AM - PR Newswire


Genentech to Present Clinical Data from Six Different Medicines at American Society of Hematology (ASH) Annual Meeting
12/5/2014 11:30:00 AM - Business Wire


FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer
11/14/2014 1:11:00 PM - Business Wire


Roche Teams Up with LabCentral to Support Biotech Startups
11/12/2014 8:30:00 AM - PR Newswire


Rogers Corporation to Participate in Baird’s 2014 Industrial Conference
11/4/2014 8:15:00 AM - Business Wire
▲14.41 % Price Change since this news event. The Volume Ratio is 0.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Rogers Corporation Reports All-Time Record Quarterly Sales for the Third Quarter of 2014
10/28/2014 4:01:00 PM - Business Wire
▲33.16 % Price Change since this news event. The Volume Ratio is 7.17.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ventana announces collaboration to develop companion diagnostics for ImmunoGen''s targeted anticancer agents
10/28/2014 11:00:00 AM - PR Newswire


Rogers Corporation Invites You to Join its Third Quarter 2014 Conference Call
10/21/2014 8:27:00 AM - Business Wire
▲44.54 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA® in Lymphoma and Leukemia
10/16/2014 2:45:00 PM - PR Newswire


FDA Approves Esbriet® (pirfenidone) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) in the United States
10/15/2014 4:40:00 PM - Business Wire


Rogers Corporation Appoints Helene Simonet to Its Board of Directors
10/14/2014 4:00:00 PM - Business Wire
▲48.22 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Grants Priority Review for Genentech’s Lucentis in Diabetic Retinopathy
10/8/2014 11:30:00 AM - Business Wire


Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market
9/30/2014 10:00:00 AM - PR Newswire


Genentech’s Investigational Combination of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit to People With Advanced Melanoma Over Zelboraf Alone
9/29/2014 3:00:00 AM - Business Wire


Genentech’s Perjeta Regimen Extended the Lives of People With an Aggressive Type of Metastatic Breast Cancer by 15.7 Months Compared to Herceptin and Chemotherapy
9/28/2014 3:01:00 AM - Business Wire


Roche launches Global Access Program for HIV viral load testing
9/25/2014 6:33:00 PM - PR Newswire


Roche launches Global Access Program for HIV viral load testing
9/25/2014 6:33:00 PM - PR Newswire